As of 2024-07-27, the Relative Valuation of Amphastar Pharmaceuticals Inc (AMPH) is 29.72 USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.48 USD, the upside of Amphastar Pharmaceuticals Inc based on Relative Valuation is -30.0%.
The range of the Relative Valuation is 20.56 - 42.61 USD.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 9.4x | 8.0x |
| Forward P/E multiples | 8.3x - 13.6x | 11.0x |
| Fair Price | 20.56 - 42.61 | 29.72 |
| Upside | -51.6% - 0.3% | -30.0% |
| Date | P/E |
| 2024-07-26 | 13.43 |
| 2024-07-25 | 13.33 |
| 2024-07-24 | 13.02 |
| 2024-07-23 | 12.82 |
| 2024-07-22 | 12.86 |
| 2024-07-19 | 12.53 |
| 2024-07-18 | 12.57 |
| 2024-07-17 | 12.47 |
| 2024-07-16 | 12.53 |
| 2024-07-15 | 12.26 |
| 2024-07-12 | 12.24 |
| 2024-07-11 | 12.39 |
| 2024-07-10 | 11.82 |
| 2024-07-09 | 11.70 |
| 2024-07-08 | 11.82 |
| 2024-07-05 | 11.94 |
| 2024-07-03 | 12.19 |
| 2024-07-02 | 11.88 |
| 2024-07-01 | 12.18 |
| 2024-06-28 | 12.65 |
| 2024-06-27 | 12.76 |
| 2024-06-26 | 12.66 |
| 2024-06-25 | 12.83 |
| 2024-06-24 | 12.91 |
| 2024-06-21 | 12.79 |
| 2024-06-20 | 12.58 |
| 2024-06-18 | 12.66 |
| 2024-06-17 | 12.82 |
| 2024-06-14 | 12.80 |
| 2024-06-13 | 12.85 |
| 2024-06-12 | 12.79 |
| 2024-06-11 | 13.01 |
| 2024-06-10 | 13.17 |
| 2024-06-07 | 12.87 |
| 2024-06-06 | 12.95 |
| 2024-06-05 | 13.29 |
| 2024-06-04 | 13.35 |
| 2024-06-03 | 13.36 |
| 2024-05-31 | 13.39 |
| 2024-05-30 | 13.33 |
| 2024-05-29 | 13.17 |
| 2024-05-28 | 13.27 |
| 2024-05-24 | 13.68 |
| 2024-05-23 | 13.71 |
| 2024-05-22 | 13.74 |
| 2024-05-21 | 13.25 |
| 2024-05-20 | 13.62 |
| 2024-05-17 | 13.75 |
| 2024-05-16 | 13.51 |
| 2024-05-15 | 13.42 |